Product Information
OMEPRAZOLE-BICARB 20-1,680 PKT is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $8.1125 per EA under NDC 70954079720. Its NADAC has been published 32 times since Feb 25, 2026.
FDA first approved this application on Dec 10, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20; 1680 mg/1; mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
70954079720
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
Generic (ANDA)
FDA Application
ANDA219161FDA Approved
12/10/2025
TE Code
AB
On Market Since
1/15/2026
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has been published 32 times since Feb 25, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.1125 per EA |
|---|---|
| All-time high | $8.1125 (Sep 30, 2026) |
| All-time low | $7.3740 (Jul 22, 2026) |
| 52-week high | $8.1125 |
| 52-week low | $7.3740 |
| Median price | $7.8063 |
| Average price | $7.7365 |
| Largest weekly change | +5.9% (Aug 19, 2026) |
| Weeks tracked | 32 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Omeprazole and Sodium Bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Omeprazole and Sodium Bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE-BICARB 20-1,680 PKT?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 20-1,680 PKT, manufactured by ANI Pharmaceuticals, Inc., is $8.1125 per EA (NDC 70954079720), effective Sep 30, 2026.
How has the price of OMEPRAZOLE-BICARB 20-1,680 PKT changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has held within roughly two percent of its current level. It has been tracked across 32 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 20-1,680 PKT?
Since Feb 25, 2026, the NADAC for OMEPRAZOLE-BICARB 20-1,680 PKT has ranged from a low of $7.3740 (Jul 22, 2026) to a high of $8.1125 (Sep 30, 2026), with a median of $7.8063 per EA.
Are there cheaper alternatives to OMEPRAZOLE-BICARB 20-1,680 PKT?
No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 20-1,680 PKT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEPRAZOLE-BICARB 20-1,680 PKT?
OMEPRAZOLE-BICARB 20-1,680 PKT (NDC 70954079720) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.